Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2023-12-05 Regulatory Filings
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항([국책과제 선정]first in class tie2 activator PMC-403의 연령관련 황반변성 환자대상 임상 1상 연구)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details the selection of a government-funded research project for a clinical trial (PMC-403). Since this is a specific regulatory disclosure of a material business event that does not fit into categories like financial reports, dividends, or share transactions, it falls under the general regulatory filing category.
2023-12-05 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from PharmAbcine regarding a 'Capital Increase Decision' (유상증자결정). It specifically details the cancellation of a previously announced capital increase (유상증자 철회). In the context of financial filings, announcements regarding capital structure changes, including share issuance or cancellation of such plans, fall under the 'Share Issue/Capital Change' category.
2023-12-01 Korean
기타주요경영사항(제3자배정 유상증자 철회)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory announcement regarding the cancellation of a third-party capital increase (private placement). It details the withdrawal of a previously announced capital raise due to non-payment by the designated parties. This falls under the category of capital structure changes and financing updates.
2023-12-01 Korean
투자판단관련주요경영사항(경영지배인 해임의 건)
Board/Management Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'major management matter' (투자판단 관련 주요경영사항). Specifically, it announces the dismissal of a business manager (경영지배인 해임의 건). Since this pertains to a change in senior management/key personnel, it falls under the 'Board/Management Information' category.
2023-11-30 Korean
[기재정정]주주총회소집결의(임시주주총회)
AGM Information Classification · 98% confidence The document is a formal regulatory filing titled '주주총회소집결의' (Resolution for Convening a General Meeting) and '정정신고' (Correction Report). It details the agenda for an upcoming Extraordinary General Meeting, including board member appointments and business purpose changes. This falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on specific agenda items for a meeting.
2023-11-27 Korean
[기재정정]주주총회소집결의(임시주주총회)
AGM Information Classification · 98% confidence The document is a formal regulatory filing titled '주주총회소집결의' (Resolution for Convening a General Meeting of Shareholders) and is a '정정신고' (Correction Report) regarding an Extraordinary General Meeting. It details the agenda items, including board member appointments and changes to business purposes. This type of document is a standard proxy-related regulatory filing used to inform shareholders of upcoming meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement category.
2023-11-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.